Benzodiazepines and Grapefruit Interaction

Introduction to the Risk

The American College of Cardiology recommends complete avoidance of grapefruit for medications metabolized by CYP3A4 to prevent increased drug bioavailability and potential toxicity 1

Grapefruit juice irreversibly inactivates intestinal CYP3A4 enzymes, reducing first-pass metabolism and increasing oral bioavailability of susceptible drugs, with the effect persisting up to 24 hours after a single serving 1
The interaction cannot be avoided by separating administration times, as the effect is not about concurrent ingestion but about enzyme destruction 1
The interaction occurs with all grapefruit products, including fresh fruit, juice, preserves, extracts, and zest 1

When grapefruit inhibits CYP3A4, benzodiazepine levels can increase substantially, leading to excessive sedation and cognitive impairment 1
Respiratory depression is a significant risk, particularly concerning in elderly or those with pulmonary disease 1
Increased fall risk is especially problematic in older adults 2

Elderly patients face compounded danger due to increased sensitivity to benzodiazepine effects, elevated baseline risk for falls, ataxia, and oversedation, and frequent consumption of grapefruit juice 2
The 2019 AGS Beers Criteria emphasizes avoiding benzodiazepines in older adults due to sedation, cognitive impairment, falls, and motor skill impairment 3

For patients currently taking high-risk benzodiazepines, instruct complete elimination of all grapefruit products, explain the interaction persists for days, and recommend safe citrus alternatives like oranges and lemons 1
Monitor for signs of increased benzodiazepine effect, including excessive sedation, confusion, respiratory depression, and nausea 1

Patients taking benzodiazepines should also avoid other CYP3A4 inhibitors, such as azole antifungals, macrolide antibiotics, calcium channel blockers, and HIV protease inhibitors 1, 3
The combination of benzodiazepines with opioids should be avoided entirely due to additive CNS depression and respiratory depression risk 3